What is 'stable disease' in multiple myeloma?

FAQ Library published on March 6, 2013 in Response Assessment, General Education
Download Transcript Download Audio
Rafael Fonseca, MD
Deputy Director, Mayo Clinic Cancer Center
Getz Family Professor of Cancer
Professor of Medicine, Mayo Clinic College of Medicine
Site Director, Hematological Malignancies, Mayo Clinic
Scottsdale, Arizona

Hi, Rafael Fonseca here, I am frequently asked what constitutes stable disease in the context of myeloma. This has different meaning whether the patient is in a relapsed or refractory state versus a patient who is receiving therapy for front-line myeloma. But it is essentially any patient who does not meet criteria for the aforementioned categories. I suspect in the future, versions of this response criteria, we might introduce minor response, that has been shown to have clinical benefit in the setting of relapsed and refractory myeloma. But as it stands right now, as we look at patients who have no evidence of any of the aforementioned responses.

Reviewed on January 17, 2017 for clinical relevance.

Last modified: February 8, 2017
Related Items by Category
How can you ensure patients are reporting side effects?
FAQ Library published on May 9, 2013 in Response Assessment, Comorbidities/SEs
What constitutes a very good partial response in multiple myeloma?
FAQ Library published on March 6, 2013 in Response Assessment, General Education
What is the difference between complete response and stringent complete response?
FAQ Library published on March 4, 2013 in Response Assessment, General Education
When do I refer a relapsed/refractory patient to a clinical trial?
FAQ Library published on February 9, 2012 in General Education, Patient Communication, Nurses & Pharmacists, Clinical Trials
What are effective ways to ensure patient compliance?
FAQ Library published on April 20, 2011 in General Education, Patient Communication, Patient Education, Nurses & Pharmacists
Is there a role for multidisciplinary care in the treatment of multiple myeloma?
FAQ Library published on December 9, 2009 in General Education
What is the important endpoint to look for in multiple myeloma studies?
FAQ Library published on July 22, 2009 in Response Assessment
Related Items by Author
What constitutes a very good partial response in multiple myeloma?
Rafael Fonseca, MD
FAQ Library published on March 6, 2013 in Response Assessment, General Education
What is the difference between complete response and stringent complete response?
Rafael Fonseca, MD
FAQ Library published on March 4, 2013 in Response Assessment, General Education